Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10019602HBVENSG00000198785.7protein_codingGRIN3ANoNo116443Q8TCU5
TVIS10018253HBVENSG00000198785.7protein_codingGRIN3ANoNo116443Q8TCU5
TVIS10005829HBVENSG00000198785.7protein_codingGRIN3ANoNo116443Q8TCU5
TVIS10005828HBVENSG00000198785.7protein_codingGRIN3ANoNo116443Q8TCU5
TVIS10033234HBVENSG00000198785.7protein_codingGRIN3ANoNo116443Q8TCU5
TVIS10036190HBVENSG00000198785.7protein_codingGRIN3ANoNo116443Q8TCU5
TVIS10019936HBVENSG00000198785.7protein_codingGRIN3ANoNo116443Q8TCU5
TVIS10020135HBVENSG00000198785.7protein_codingGRIN3ANoNo116443Q8TCU5
TVIS10042400HBVENSG00000198785.7protein_codingGRIN3ANoNo116443Q8TCU5
TVIS10062547HBVENSG00000198785.7protein_codingGRIN3ANoNo116443Q8TCU5
TCGA Plot Options
Drug Information
GeneGRIN3A
DrugBank IDDB01221
Drug NameKetamine
Target IDBE0000641
UniProt IDQ8TCU5
Regulation Typeantagonist
PubMed IDs17502428; 2858237; 18175098; 14740534
CitationsSmothers CT, Woodward JJ: Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits. J Pharmacol Exp Ther. 2007 Aug;322(2):739-48. Epub 2007 May 14.@@Harrison NL, Simmonds MA: Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985 Feb;84(2):381-91.@@Sinner B, Graf BM: Ketamine. Handb Exp Pharmacol. 2008;(182):313-33. doi: 10.1007/978-3-540-74806-9_15.@@Radovanovic D, Pjevic M: [Ketamine: the past 30 years and its future]. Med Pregl. 2003 Sep-Oct;56(9-10):439-45.
GroupsApproved; Vet_approved
Direct ClassificationChlorobenzenes
SMILESCNC1(CCCCC1=O)C1=CC=CC=C1Cl
Pathways
PharmGKBPA450144
ChEMBLCHEMBL742